期刊文献+

咖啡因-氟烷骨骼肌收缩试验用于恶性高热的明确诊断 被引量:7

Application of Caffeine-Halothane Contracture Test in the Diagnosis of Malignant Hyperthermia
下载PDF
导出
摘要 目的 应用咖啡因-氟烷骨骼肌收缩试验(CHCT)明确恶性高热(MH)的诊断。方法对1例行胃癌根治术、在常规静脉吸入复合麻醉过程中出现MH临床表现的患者立即停止吸入异氟醚、停止手术,采取物理降温等紧急抢救措施;同时检测血清肌酸激酶(CK)、血清和尿肌红蛋白,取腹直肌进行CHCT。通过DNA测序对患者蓝尼定受体-1(RYRI)基因外显子2-18、39-46及90-104进行突变筛查。结果患者血清、尿肌红蛋白及血清CK术后持续升高,超过正常值30倍以上,结合其他临床表现诊断该患者为MH发作。尽管氟烷试验阴性,但是咖啡因试验阳性,根据CHCT诊断标准,确诊该患者为MH患者。患者的RYRI基因第6724位碱基C突变为T(c.6724C〉T),导致其编码的第2206位氨基酸由苏氨酸变为甲硫氨酸(P.T2206M)。结论CHCT可用于MH的明确诊断。 Objective To explore the application of caffeine-halothane contracture test (CHCT) in the confirmation of malignant hyperthermia (MH). Methods One patient who underwent radical gastrectomy presented with clinical manifestations of MH during routine intravenous-inhalation anesthesia process. Isoflurane inhalation and the operation were ceased immediately and emergency management approaches such as physical cooling therapy were taken. Meanwhile, the levels of serum creatine kinase (CK) , serum myoglobin, and urinary myoglobin were examined and rectus abdominis was taken and then CHCT was performed to confirm the clinical diagnosis. Total genome was extracted from the patient and then exons 2-18, 39-46, and 90-104 of ryanodine receptor 1 ( RYR1 ) gene were screened to detect mutations using DNA sequencing technique. Results The patient was diagnosed as MH episode by clinical characteristics and postoperatively continuous elevation of the levels of CK, serum myoglobin, and urinary myoglobin ( 30 times higher than normal level). Despite halothane test was negative, the diagnosis of MH was verified by the positive result of caffeine test. DNA sequencing of RYR1 gene of the patient revealed c. 6 724C 〉 T ( p. T 2 206M). Conclusion CHCT can be used to confirm the diagnosis of MH.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2008年第2期182-186,共5页 Acta Academiae Medicinae Sinicae
关键词 咖啡因-氟烷骨骼肌收缩试验 恶性高热 诊断 治疗 caffeine-halothane contracture test malignant hyperthermia diagnosis treatment
  • 相关文献

参考文献12

  • 1Abraham RB, Adnet P, Glauber V, et al. Malignant hyper-thermia [J]. Postgrad Med J, 1998, 74(867) :11-17.
  • 2Hopkins PM. Malignant hyperthermia: advances in clinical management and diagnosis [ J ]. Br J Anaesth, 2000, 85 (1) :118-128.
  • 3王颖林,郭向阳,罗爱伦.我国大陆恶性高热病例的分析[J].中华麻醉学杂志,2006,26(2):107-109. 被引量:45
  • 4Gunilla I, Eva RT. Comparison between the European and North American protocols for diagnosis of malignant hyper-thermia susceptibility in humans [ J ]. Anesth Analg, 1999, 88(5) :1155-1160.
  • 5Litman RS, Rosenberg H. Malignant hyperthermia: update on susceptibility testing [ J ]. JAMA, 2005, 293 (23) : 2918-2924.
  • 6王颖林,郭向阳,罗爱伦.恶性高热诊断和治疗的研究进展[J].中华麻醉学杂志,2006,26(1):92-94. 被引量:22
  • 7Sambuughin N, Muldoon S, Barbara BW. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population [ J ]. Anaesthesiology, 2005, 102(3) :515-521.
  • 8Mauritz W, Hackl W, Winkler M. Malignant hyperthermia: state of the art [J]. Acta Anaesthesiol Scand, 1997, 111 (suppl) :310-312.
  • 9McCarthy EJ. Malignant h yperthermia: pathophysiology, clinical presentation, and treatment [J]. AACN Clin Issues, 2004, 15(2):231-237.
  • 10Girard T, Treves S, Voronkov E, et al. Molecular genetic testing for malignant hyperthermia susceptibility [ J ]. Anesthesiology, 2004, 100(5) :1076-1080.

二级参考文献43

  • 1孔琴,周期.儿童术后恶性高热二例报告[J].海南医学,2001,12(9):95-96. 被引量:1
  • 2张伯勋,卢世璧.恶性高热的术前预测及其防治[J].中华外科杂志,1993,31(5):298-300. 被引量:2
  • 3唐瞻贵,王永贵,郭新程,顾湘.唇裂全麻术后恶性高热的诊断与治疗[J].华西口腔医学杂志,1996,14(1):41-44. 被引量:6
  • 4Harrison G.Dosage of dantrolene:"empiric"please! Anaesth Intensive Care,2003,31:122.
  • 5McCarthy EJ.Malignant hyperthermia:pathophysiology,clinical presentation,and treatment.AACN Clin Issues,2004,15:231-237.
  • 6Larach MG,Localio AR,Allen GC,et al.A clinical grading scale to predict malignant hyperthermia susceptibility.Anesthesiology,1994,80:771-779.
  • 7Hopkins PM.Malignant hyperthermia:advances in clinical management and diagnosis.Br J Anaesth,2000,85:118-128.
  • 8Islander G,Twetman ER.Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans.Anesth Analg,1999,88:1155-1160.
  • 9Bendahan D,Guis S,Monnier N,et al.Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine:a comparative investigation in malignant hyperthermia.Acta Anaesthesiol Scand,2004,8:1019-1027.
  • 10Bendahan D,Kozak Ribbens G,Rodet L,et al.31 Phosphorus magnetic resonance spectroscopy characterization of musclular metabolic anomalies in patients with malignant hyperthermia:application to diagnosis.Anesthesiology,1998,88:96-107.

共引文献56

同被引文献41

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部